ASHLEY SCOTT: Open Payments
NPI 1669049078 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 68 payments from 21 companies in 2025. Trend: 2023 $477 · 2024 $687 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 9 | $188 |
| Phathom Pharmaceuticals, Inc. | 8 | $171 |
| ABBVIE INC. | 13 | $149 |
| Xeris Pharmaceuticals, Inc. | 5 | $99 |
| PFIZER INC. | 4 | $75 |
| Medtronic, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Exact Sciences Corporation | 3 | $52 |
Products named: ZORYVE, VOQUEZNA, VRAYLAR, GVOKE HYPOPEN, NURTEC ODT, REXULTI, INGREZZA, Veozah.
Industry payments across FL — which companies pay providers there.
